Home>Topics>Stocks>Impax Laboratories

Impax Laboratories IPXL

  1. All
  2. Commentary
  3. Headlines
    1. Genervon ALS drug shows encouraging results

      Headlines

      Mon, 20 Oct 2014

      NASDAQ: BIIB ) PD-related tickers: (NASDAQ: ACOR ) (Pending: CVTS ) (NASDAQ: ACAD ) ( OTCQX:CYNAF ) (NASDAQ: IPXL ) ( OTCQB:TTNP ) ( OTCQB:SGTH ) (NYSE: TEVA ) (NASDAQ: ADMS ) (NASDAQ: PRAN ) (NASDAQ: CHTP ) (NASDAQ: PRTA

    2. UPDATE 2-Impax Labs on the hunt after striking two deals worth $700 mln

      Headlines

      Thu, 9 Oct 2014

      Oct 9 (Reuters) - Impax Laboratories Inc said it was on the hunt for further deals - and would consider a so-called "tax inversion" transaction - after its acquisition of two privately held...

    3. Midday Gainers / Losers

      Headlines

      Thu, 9 Oct 2014

      Top 10 Gainers: LAKE +44% . DYNT +22% . PRTS +19% . RT +16% . GTIV +16% . APT +14% . EMAN +14% . ESI +12% . IPXL +11% . RENT +11% . Top 10 Losers: EOPN -28% . ARCW -24% . KFX -20% . EXXI -17% . OTCQB:VPCO -16% . SZYM -15

    4. Impax buys Tower Holdings and Lineage Therapeutics

      Headlines

      Thu, 9 Oct 2014

      Impax Laboratories ( IPXL +13.9% ) acquires Tower Holdings, including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, and Lineage

    5. Impax buys two private drugmakers for $700 mln

      Headlines

      Thu, 9 Oct 2014

      Oct 9 (Reuters) - Impax Laboratories Inc said it bought two privately held drugmakers for $700 million to gain access to seven generic drugs.

    6. Impax to report on November 4

      Headlines

      Tue, 7 Oct 2014

      Impax Laboratories ( IPXL -1% ) will report Q3 results on November 4 before the open. The conference call will begin at 8:30 am ET. Consensus view is EPS of $0.29 on revenues of $149M. Post your comment!

    7. U.S. FDA raises concerns about Impax's Taiwanese plant

      Headlines

      Tue, 29 Jul 2014

      July 29 (Reuters) - Impax Laboratories Inc said the U.S. Food and Drug Administration issued "certain observations" after an inspection of the company's manufacturing plant in Taiwan.

    8. Impax shares fall after FDA denies approval to Parkinson's drug

      Headlines

      Tue, 22 Jan 2013

      (Reuters) - Shares of Impax Laboratories Inc fell as much as 10 percent on Tuesday, after U.S. health regulators denied approval to the company's Parkinson's drug and asked for a reinspection of its...

    9. Impax gets FDA warning letter, shares fall

      Headlines

      Mon, 6 Jun 2011

      (Reuters) - Impax Laboratories Inc said it received a warning letter from U.S. health regulators on deficient sampling and testing of drugs at its Hayward, California-based plant, sending the...

    10. Prospects Brighten for Medicis' Solodyn

      Commentary

      Fri, 8 Oct 2010

      competition until late 2011, thanks to several deals with Teva TEVA, Sandoz (a unit of Novartis NVS), Mylan MYL, and Impax IPXL . By paying the generic companies to delay competition, Medicis has lengthened the runway for Solodyn. The firm may have bought

    « Prev123Next »
    Content Partners